1 Subcutaneous Drug Delivery Equipment Market Overview
1.1 Product Overview and Scope of Subcutaneous Drug Delivery Equipment
1.2 Subcutaneous Drug Delivery Equipment Segment by Type
1.2.1 Global Subcutaneous Drug Delivery Equipment Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Syringe Based Subcutaneous Drug Delivery
1.2.3 Subcutaneous Implants
1.2.4 Pen Systems for Subcutaneous Drug Delivery
1.2.5 Auto Injectors
1.2.6 Pump Based Drug Delivery Systems
1.3 Subcutaneous Drug Delivery Equipment Segment by Application
1.3.1 Global Subcutaneous Drug Delivery Equipment Sales Comparison by Application: (2022-2028)
1.3.2 In-Patient
1.3.3 Out-Patient
1.3.4 Clinic
1.3.5 Others
1.4 Global Subcutaneous Drug Delivery Equipment Market Size Estimates and Forecasts
1.4.1 Global Subcutaneous Drug Delivery Equipment Revenue 2017-2028
1.4.2 Global Subcutaneous Drug Delivery Equipment Sales 2017-2028
1.4.3 Subcutaneous Drug Delivery Equipment Market Size by Region: 2017 Versus 2021 Versus 2028
2 Subcutaneous Drug Delivery Equipment Market Competition by Manufacturers
2.1 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Manufacturers (2017-2022)
2.2 Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Subcutaneous Drug Delivery Equipment Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Subcutaneous Drug Delivery Equipment Manufacturing Sites, Area Served, Product Type
2.5 Subcutaneous Drug Delivery Equipment Market Competitive Situation and Trends
2.5.1 Subcutaneous Drug Delivery Equipment Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Subcutaneous Drug Delivery Equipment Players Market Share by Revenue
2.5.3 Global Subcutaneous Drug Delivery Equipment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Subcutaneous Drug Delivery Equipment Retrospective Market Scenario by Region
3.1 Global Subcutaneous Drug Delivery Equipment Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Subcutaneous Drug Delivery Equipment Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Subcutaneous Drug Delivery Equipment Market Facts & Figures by Country
3.3.1 North America Subcutaneous Drug Delivery Equipment Sales by Country
3.3.2 North America Subcutaneous Drug Delivery Equipment Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Subcutaneous Drug Delivery Equipment Market Facts & Figures by Country
3.4.1 Europe Subcutaneous Drug Delivery Equipment Sales by Country
3.4.2 Europe Subcutaneous Drug Delivery Equipment Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Subcutaneous Drug Delivery Equipment Market Facts & Figures by Region
3.5.1 Asia Pacific Subcutaneous Drug Delivery Equipment Sales by Region
3.5.2 Asia Pacific Subcutaneous Drug Delivery Equipment Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Subcutaneous Drug Delivery Equipment Market Facts & Figures by Country
3.6.1 Latin America Subcutaneous Drug Delivery Equipment Sales by Country
3.6.2 Latin America Subcutaneous Drug Delivery Equipment Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Subcutaneous Drug Delivery Equipment Market Facts & Figures by Country
3.7.1 Middle East and Africa Subcutaneous Drug Delivery Equipment Sales by Country
3.7.2 Middle East and Africa Subcutaneous Drug Delivery Equipment Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Subcutaneous Drug Delivery Equipment Historic Market Analysis by Type
4.1 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2017-2022)
4.2 Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Type (2017-2022)
4.3 Global Subcutaneous Drug Delivery Equipment Price by Type (2017-2022)
5 Global Subcutaneous Drug Delivery Equipment Historic Market Analysis by Application
5.1 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2017-2022)
5.2 Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Application (2017-2022)
5.3 Global Subcutaneous Drug Delivery Equipment Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Boehringer Ingelheim Subcutaneous Drug Delivery Equipment Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Eli Lily
6.2.1 Eli Lily Corporation Information
6.2.2 Eli Lily Description and Business Overview
6.2.3 Eli Lily Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Eli Lily Subcutaneous Drug Delivery Equipment Product Portfolio
6.2.5 Eli Lily Recent Developments/Updates
6.3 Galaxo
6.3.1 Galaxo Corporation Information
6.3.2 Galaxo Description and Business Overview
6.3.3 Galaxo Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Galaxo Subcutaneous Drug Delivery Equipment Product Portfolio
6.3.5 Galaxo Recent Developments/Updates
6.4 HMD pharmaceuticals
6.4.1 HMD pharmaceuticals Corporation Information
6.4.2 HMD pharmaceuticals Description and Business Overview
6.4.3 HMD pharmaceuticals Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2017-2022)
6.4.4 HMD pharmaceuticals Subcutaneous Drug Delivery Equipment Product Portfolio
6.4.5 HMD pharmaceuticals Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Merck Subcutaneous Drug Delivery Equipment Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Novartis Subcutaneous Drug Delivery Equipment Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novo Nordisk Subcutaneous Drug Delivery Equipment Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Pfizer Subcutaneous Drug Delivery Equipment Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Sanofi Subcutaneous Drug Delivery Equipment Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Teva Pharmaceutical
6.10.1 Teva Pharmaceutical Corporation Information
6.10.2 Teva Pharmaceutical Description and Business Overview
6.10.3 Teva Pharmaceutical Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Teva Pharmaceutical Subcutaneous Drug Delivery Equipment Product Portfolio
6.10.5 Teva Pharmaceutical Recent Developments/Updates
6.11 Zogenix
6.11.1 Zogenix Corporation Information
6.11.2 Zogenix Subcutaneous Drug Delivery Equipment Description and Business Overview
6.11.3 Zogenix Subcutaneous Drug Delivery Equipment Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Zogenix Subcutaneous Drug Delivery Equipment Product Portfolio
6.11.5 Zogenix Recent Developments/Updates
7 Subcutaneous Drug Delivery Equipment Manufacturing Cost Analysis
7.1 Subcutaneous Drug Delivery Equipment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Subcutaneous Drug Delivery Equipment
7.4 Subcutaneous Drug Delivery Equipment Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Subcutaneous Drug Delivery Equipment Distributors List
8.3 Subcutaneous Drug Delivery Equipment Customers
9 Subcutaneous Drug Delivery Equipment Market Dynamics
9.1 Subcutaneous Drug Delivery Equipment Industry Trends
9.2 Subcutaneous Drug Delivery Equipment Market Drivers
9.3 Subcutaneous Drug Delivery Equipment Market Challenges
9.4 Subcutaneous Drug Delivery Equipment Market Restraints
10 Global Market Forecast
10.1 Subcutaneous Drug Delivery Equipment Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Subcutaneous Drug Delivery Equipment by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Subcutaneous Drug Delivery Equipment by Type (2023-2028)
10.2 Subcutaneous Drug Delivery Equipment Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Subcutaneous Drug Delivery Equipment by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Subcutaneous Drug Delivery Equipment by Application (2023-2028)
10.3 Subcutaneous Drug Delivery Equipment Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Subcutaneous Drug Delivery Equipment by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Subcutaneous Drug Delivery Equipment by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
